Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$39.15 -0.14 (-0.36%)
As of: Sep 30, 2026 · 2:22 PM EDT

Harmony Biosciences Holdings (HRMY) Gross Margin (2020 - 2026)

Updated

Harmony Biosciences Holdings (HRMY) reported Gross Margin of 75.81% for Q2 2026, down 5.16 percentage points from 80.97% a year earlier and down 3.52 percentage points from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) Gross Margin (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Harmony Biosciences Holdings' Gross Margin came in at 75.42%, down 2.92 percentage points year-over-year; for FY2025, it came in at 77.16%, down 0.90 percentage points from FY2024.

  • Gross Margin has declined for five consecutive years, with a five-year change of -5.47 percentage points (FY2020 to FY2025).
  • By year, Gross Margin came in at 78.06% in FY2024 (-1.11 pp), 79.17% in FY2023 (-1.76 pp), 80.93% in FY2022 (-0.89 pp) and 81.82% in FY2021 (-0.81 pp).
  • Five-year quarterly Gross Margin spans a low of 71.88% in Q4 2025 and a high of 82.75% in Q1 2022.
  • Year over year, Gross Margin has now declined in each of the last five quarters, with an average year-over-year change of -1.97 percentage points over the last eight quarters.
  • The high point for year-over-year Gross Margin in five years was Q1 2025 (a gain of 0.46 percentage points); the low point was Q2 2026 (a drop of 5.16 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 79.33% (Q1 2026), 71.88% (Q4 2025) and 75.09% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 68.19%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 74.74%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 73.54%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 78.02%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 83.60%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 72.04%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 85.33%
10 Harmony Biosciences Holdings 2.28 Bn -473.07 Mn 198.08 Mn 75.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.81%
Mar 31, 2026 79.33%
Dec 31, 2025 71.88%
Sep 30, 2025 75.09%
Jun 30, 2025 80.97%
Mar 31, 2025 82.68%
Dec 31, 2024 72.97%
Sep 30, 2024 77.01%
Jun 30, 2024 81.40%
Mar 31, 2024 82.22%
Dec 31, 2023 74.38%
Sep 30, 2023 79.85%
Jun 30, 2023 81.37%
Mar 31, 2023 82.56%
Dec 31, 2022 79.05%
Sep 30, 2022 80.41%
Jun 30, 2022 82.32%
Mar 31, 2022 82.75%
Dec 31, 2021 80.47%
Sep 30, 2021 81.91%
API Access

Harmony Biosciences Holdings Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=HRMY&period=max&api_key=YOUR_API_KEY